Clinical Trial Update: A Study of STSP-0902 Ophthalmic Solution in Healthy Subjects [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the safety and tolerability of STSP-0902 ophthalmic solution in healthy volunteers has been completed for neurotrophic keratitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurotrophic Keratitis

Drugs mentioned

• STSP-0902 ophthalmic solution

Snippet

Sponsor: Staidson (Beijing) Biopharmaceuticals Co., Ltd | Conditions: Neurotrophic Keratitis | Phase 1 | Status: COMPLETED